Comerica Bank Sells 13,439 Shares of Zoetis Inc. $ZTS

Key Points

• Comerica Bank trimmed its Zoetis stake by 8.3% in Q4, selling 13,439 shares and retaining 148,304 shares valued at $18.66 million.
• Analyst sentiment is mixed — seven Buy, seven Hold and one Sell — resulting in a consensus rating of Hold and a consensus price target of $152.25.
• Zoetis topped quarterly estimates (EPS $1.48 vs. $1.40; revenue $2.39B vs. $2.36B), set FY2026 guidance of $7.00–$7.10 EPS, and declared a $0.53 quarterly dividend (annualized $2.12, ~1.8% yield).

Comerica Bank lessened its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 148,304 shares of the company's stock after selling 13,439 shares during the period. Comerica Bank's holdings in Zoetis were worth $18,660,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Global Wealth Strategies & Associates bought a new stake in shares of Zoetis during the 4th quarter valued at $25,000. Lodestone Wealth Management LLC bought a new stake in shares of Zoetis during the 4th quarter valued at $30,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Zoetis during the 3rd quarter valued at $31,000. Holos Integrated Wealth LLC bought a new stake in shares of Zoetis during the 4th quarter valued at $32,000. Finally, Board of the Pension Protection Fund bought a new stake in shares of Zoetis during the 4th quarter valued at $38,000. Institutional investors own 92.80% of the company's stock.

Get Zoetis SMS alerts:

Sign Up

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Leerink Partners reissued a "market perform" rating on shares of Zoetis in a research report on Tuesday, March 10th. Bank of America boosted their price objective on shares of Zoetis from $135.00 to $140.00 and gave the company a "neutral" rating in a research report on Friday, February 13th. Wall Street Zen raised shares of Zoetis from a "hold" rating to a "buy" rating in a research report on Saturday, February 21st. Citigroup assumed coverage on shares of Zoetis in a research report on Wednesday, April 15th. They set a "buy" rating and a $145.00 price objective for the company. Finally, William Blair reissued an "outperform" rating on shares of Zoetis in a research report on Monday, March 2nd. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $152.25.

Zoetis Trading Up 0.8%

Shares of Zoetis stock opened at $117.85 on Tuesday. The company has a market capitalization of $49.57 billion, a P/E ratio of 19.58, a P/E/G ratio of 1.78 and a beta of 0.98. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03. The company has a fifty day moving average of $120.65 and a 200 day moving average of $125.10. Zoetis Inc. has a fifty-two week low of $113.29 and a fifty-two week high of $172.23.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. Zoetis's quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 7.02 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 1.8%. Zoetis's dividend payout ratio is currently 35.22%.

Zoetis Company Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.